Navigation Links
New Strategy Eyed for AIDS Treatment
Date:6/22/2009

Discovery of HIV hiding places may pave way for novel therapies

MONDAY, June 22 (HealthDay News) -- A radical new therapy could improve treatment of people with HIV-AIDS by destroying the viruses circulating in the body as well as those hiding in immune system cells, according to a new study.

A team of American and Canadian researchers have high hopes for a combination of targeted chemotherapy and what's known as highly active anti-retroviral (HAART) treatments.

When HIV viruses hide in immune cells, the researchers explained, existing HAART treatments can't reach them. But the study identified where HIV hides in immune cells and the "stealth" mechanisms that enable the virus to elude existing treatments. This finding could lead to new therapies that are different than current treatments, they said.

"Our results argue in favor of a strategy similar to the one used against leukemia, which is targeted chemotherapy, associated with a targeted immune treatment," study co-leader Dr. Rafick-Pierre Sekaly, a professor at the University of Montreal and scientific director of the Vaccine and Gene Therapy Institute of Florida, said in a university news release. "This would make it possible to destroy the cells containing a virus while giving the immune system time to regenerate with healthy cells."

Another co-leader, Dr. Jean-Pierre Routy, an infection and immunity researcher at the Research Institute of the McGill University Health Centre in Montreal, explained the importance of the finding.

"For the first time, this study proves that the HIV reservoirs are not due to a lack of potency of the antiretroviral drugs but to the virus hiding inside two different types of long-life CD4 memory immune cells," Routy said in the news release. "There are several types of HIV reservoirs, each necessitating a different treatment to eliminate them."

The researchers acknowledged, however, that it will take m
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast
2. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
3. NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
4. XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development
5. Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders
6. Diplomat Specialty Pharmacy Promotes Rinku A. Patel, PharmD to Vice President, Pharmacy Strategy
7. MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa
8. Sisters of Charity Health System Appoints Orlando L. Alvarez Jr. to Head Physician Strategy and Business Development
9. Cutler to Direct Debt Management Product Strategy at Ontario Systems
10. American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy
11. American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 New Strategy Eyed for AIDS Treatment
(Date:9/2/2014)... (HealthDay News) -- Many people believe that marijuana is ... "As more people are able to obtain and ... recreational use, people are less likely to perceive it ... psychiatrist at Massachusetts General Hospital,s Center for Addiction Medicine, ... shows that cannabis use can have significant consequences, and ...
(Date:9/2/2014)... Mass. (PRWEB) September 02, 2014 Healthcare ... latest and most complete oncology guidelines available at the ... Health and the National Comprehensive Cancer Network® ... with other evidence and guidelines in the content available ... , NCCN, a not-for-profit alliance of 25 of ...
(Date:9/2/2014)... involving mice suggests that the key to more youthful ... In a report published in the Journal ... from the lungs of old mice had different responses ... mice, but these changes were reversed by ibuprofen. , ... immune function," said Joanne Turner, Ph.D., a researcher involved ...
(Date:9/2/2014)... Nanomedicine is essentially based on ... and/or prevention of diseases and infections. Nanotechnology-based drugs ... and oncology diseases. , Nanomedicine is based ... nanoparticles, their medical usages, and their actions within ... for research in this domain, and scientists are ...
(Date:9/2/2014)... Durable Medical Goods manufacture ThermoTek , announced today ... LeaseQ, Inc. to help customers acquire capital goods faster ... breakthrough finance shopping platform has enabled businesses to quickly ... their business. , Said LeaseQ Vice President Cory ... team to provide customers faster access to capital and ...
Breaking Medicine News(10 mins):Health News:'Pot Addiction' May Be Real, Study Suggests 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 3Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 4Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 3Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2
... ,better for you, options; portion-controlled treats remain popular this ... ... Oct. 1 For the 93 percent of kids who will,trick-or-treat ... ever before, including more health-minded product options,available alongside the classic treats, ...
... ZURICH, Switzerland, October 1 , - Share Exchange Offer to ... & Johnson - ISIN: US4781601046 - Symbol: JNJ, The K&N ... every 1 Johnson & Johnson share a change into 1 share ... The offer period starts on 13th October 2008 and ends ...
... of almost 1,500 kidney cancer patients treated at Memorial ... as much kidney tissue as possible may improve overall ... at the time their cancer is diagnosed. The finding ... function appear to be increasing. , "In patients who ...
... is a fact that,Multi-Drug Resistant organisms are on ... medicines. According to the World Health Organization,(WHO) these ... and mortality rates, which has led to a ... safe, natural and,complementary solutions to this growing problem., ...
... says physicians have unique opportunity to help parents and ... ... Washington, DC (Vocus) October 1, 2008 ... their families understand the http://www.childrensnational.org/?utm_source=pressrelease&utm_medium=9_30&utm_campaign=driving_safety [importance of responsible driving], ...
... on the horizon, dentists, ,as well as all other medical practitioners, ... Flasch, of Flasch Business Expansion. An award winning consultant with over ... expand their practices using precise business strategies. , ... ...
Cached Medicine News:Health News:Latest Trick-or-Treats Give You Something Good to Eat 2Health News:Latest Trick-or-Treats Give You Something Good to Eat 3Health News:Latest Trick-or-Treats Give You Something Good to Eat 4Health News:Research suggests doctors should consider kidney-sparing surgery 2Health News:Research suggests doctors should consider kidney-sparing surgery 3Health News:Argentyn 23(R) Homeopathic First Aid Gel - Another World's First by Natural-Immunogenics Corp. for Healthcare Professionals 2Health News:Healthcare Providers Can Help Reduce Teen Driving Deaths 2Health News:Healthcare Providers Can Help Reduce Teen Driving Deaths 3Health News:Medical Marketing Expert Offers Dentists Tips for Thriving Down Economy After the Wall Street Dilemma 2Health News:Medical Marketing Expert Offers Dentists Tips for Thriving Down Economy After the Wall Street Dilemma 3
(Date:9/2/2014)... 2, 2014 According to ... Research "Latin America Home Healthcare Market (By Device ... Devices, Mobility Assist Devices and Medical Supplies; By ... Therapy and Unskilled Home Healthcare Services) - Industry ... - 2020" the Latin American Home Healthcare market ...
(Date:9/2/2014)... , Sept. 2, 2014   Santa Clara dentist ... a special promotion for Invisalign. Invisalign is an orthodontic ... wires. It is often the orthodontic treatment of choice ... and aesthetics of it. For a limited time, patients ... significant savings from the usual cost. This offer cannot ...
(Date:9/2/2014)...    - Los datos ... antitrombóticos no utilizados óptimamente para prevenir la apoplejía ... de GARFIELD-AF en el ESC CONGRESS 2014 ofrecen ... de pacientes en riesgo de sufrir apoplejía en ... Los datos de casi 12.500 pacientes reclutados en ...
Breaking Medicine Technology:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 3Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 4Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 5Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 6Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 7Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 8Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 9Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 10Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 11
... Oct. 6 According to Millennium Research Group ... intelligence, growth in the $2 billion US cardiac ... the expanded approval of Boston Scientific,s chronic resynchronization ... I and II patients. The New ...
... Oct. 6 e-MDs, an industry leader in ... (EHRs) and practice management (PM) solutions,  congratulates  the ... Family Medicine of Fort Collins, CO, for their ... of Excellence recipients.  The Healthcare Information and Management ...
Cached Medicine Technology:Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 3e-MDs Clients Win HIMSS Davies Awards of Excellence 2e-MDs Clients Win HIMSS Davies Awards of Excellence 3e-MDs Clients Win HIMSS Davies Awards of Excellence 4
Colloidal Gold Conjugated, Rabbit anti-goat IgG (H&L) - 12 OD...
Polyester ribbons (3) impregnated with different OD values of conjugated Protein A...
Polyester ribbon impregnated with conjugated Protein A - .50 OD per sq. cm....
Colloidal Gold Conjugated, Protein A - 12 OD...
Medicine Products: